PT891370E - Derivados 9-eteroxima 2'-protegida 3'-dimetilamina de eritromicina a - Google Patents

Derivados 9-eteroxima 2'-protegida 3'-dimetilamina de eritromicina a

Info

Publication number
PT891370E
PT891370E PT97905824T PT97905824T PT891370E PT 891370 E PT891370 E PT 891370E PT 97905824 T PT97905824 T PT 97905824T PT 97905824 T PT97905824 T PT 97905824T PT 891370 E PT891370 E PT 891370E
Authority
PT
Portugal
Prior art keywords
derivatives
erythromycin
eteroxyme
dimethylamine
protected
Prior art date
Application number
PT97905824T
Other languages
English (en)
Inventor
Jih-Hua Liu
Chengxi Yang
Hemantkumar H Patel
Yi-Kin Ku
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PT891370E publication Critical patent/PT891370E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97905824T 1996-04-02 1997-02-06 Derivados 9-eteroxima 2'-protegida 3'-dimetilamina de eritromicina a PT891370E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/627,795 US5719272A (en) 1996-04-02 1996-04-02 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives

Publications (1)

Publication Number Publication Date
PT891370E true PT891370E (pt) 2003-04-30

Family

ID=24516163

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97905824T PT891370E (pt) 1996-04-02 1997-02-06 Derivados 9-eteroxima 2'-protegida 3'-dimetilamina de eritromicina a

Country Status (9)

Country Link
US (1) US5719272A (pt)
EP (1) EP0891370B1 (pt)
JP (1) JP4116674B2 (pt)
AT (1) ATE229029T1 (pt)
DE (1) DE69717613T2 (pt)
DK (1) DK0891370T3 (pt)
ES (1) ES2188896T3 (pt)
PT (1) PT891370E (pt)
WO (1) WO1997036912A1 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0915899B1 (en) 1996-07-29 2004-08-04 Abbott Laboratories Preparation of crystal form ii of clarithromycin
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
KR100317907B1 (ko) * 1998-11-24 2001-12-24 김 완 주 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
AR023264A1 (es) * 1999-04-08 2002-09-04 Hokuriku Pharmaceutical Derivados de eritromicina
WO2000071557A1 (en) 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
GB9915745D0 (en) * 1999-07-06 1999-09-08 Biochemie Sa Organic compounds
KR20020070991A (ko) 1999-12-16 2002-09-11 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 다형체 및 신규의 다형체 ⅳ의 제조 방법
HUP0204252A3 (en) * 2000-01-11 2003-04-28 Teva Pharma Process for preparing clarithromycin polymorphs and pharmaceutical compositions containing them
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
WO2001064224A1 (en) * 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
ATE298762T1 (de) * 2001-11-07 2005-07-15 Aventis Pharma Gmbh Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
US7435805B2 (en) 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
CA2533292C (en) * 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258944B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007502296A (ja) * 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
US8062672B2 (en) * 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
WO2005023184A2 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005027877A1 (en) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp IMPROVED ABSORPTION OF MODIFIED RELEASE DOSAGE FORMS
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US20060111560A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US7595300B2 (en) 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
GB0616865D0 (en) * 2006-08-25 2007-03-28 Phoenix Chemicals Ltd Process
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
WO2010048599A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating gastrointestinal diseases
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
US9051346B2 (en) * 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
SG11201405895UA (en) 2012-03-27 2014-10-30 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
WO1992006991A1 (fr) * 1990-10-15 1992-04-30 Taisho Pharmaceutical Co., Ltd. Erythromycine modifiee en 2' ou derive de cette substance

Also Published As

Publication number Publication date
JP2000507573A (ja) 2000-06-20
DK0891370T3 (da) 2003-03-24
ATE229029T1 (de) 2002-12-15
DE69717613T2 (de) 2003-09-18
WO1997036912A1 (en) 1997-10-09
DE69717613D1 (en) 2003-01-16
EP0891370B1 (en) 2002-12-04
EP0891370A1 (en) 1999-01-20
US5719272A (en) 1998-02-17
ES2188896T3 (es) 2003-07-01
JP4116674B2 (ja) 2008-07-09

Similar Documents

Publication Publication Date Title
PT891370E (pt) Derivados 9-eteroxima 2'-protegida 3'-dimetilamina de eritromicina a
CA2279932A1 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
HK1016187A1 (en) Novel 5-o-deoaminyl 6-o-methyl erythronolide a derivatives, method for preraring the same
DE69811120D1 (de) 6-o-alkyl erythronolid-b derivate
ES8800689A1 (es) Un metodo para la metilacion selectiva del grupo hidroxi de la posicion 6 de derivados de eritromicina a
DK1044209T3 (da) Fremgangsmåde till fremstilling af 6-O-methylerythromycin A ved at anvende derivater af 9-hydroxyerythromycin
DK1032581T3 (da) Kemisk syntese af 6-O-alkyl-erythromycin A
HUP0104600A3 (en) Novel intermediates, process for preparing macrolide antibiotic agent therefrom
IL119002A0 (en) Process for producing erythromycin derivatives
CA2250736A1 (en) 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin a derivatives
DK0784605T3 (da) Selektiv fremgangsmåde til deacyleringen af acylforbindelser
HUP9900377A3 (en) Novel process for preparing 2,3-dihydro-benzofuranol derivatives
HUP9601517A2 (en) Process for producing polymorphic form i of d4t (2',3'-didehydro-3'-deoxy-timidine)
FR2749585B1 (fr) Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
BG106123A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
MY133929A (en) A cost effective method for selective methylation of erythromycin a derivatives
DE69935250D1 (de) Oleandomycin-derivate
DK0874863T3 (da) 3-deoxy-3-descladinose-derivater fra erythromycin A og B
PL315707A1 (en) Novel compounds and their salts, method of obtaining them as well as pharmaceutic preparation and method of obtaining same
NO971122L (no) Forbedret fremgangsmåte for R (+) 1,2,3,6-tetrahydro-4-fenyl-1-£(3-fenyl-3-cykloheksen-1-yl)metyl| pyridin, et sentralnervesystemmiddel
FR2736635B1 (fr) Procede de preparation d'alpha,omega-bromochloroalcanes
FR2780977B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2792637B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
ITMI981900A0 (it) Sistema di recupero di colore per macchine termiche
CA2264508A1 (en) Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase